Following the money trail from the owners of Medicare Advantage plans to the senators and president who voted no to the bill may bring out interesting contribution figures. The nominal veto of the president was very strange and unusual. Just glancing at the voting pattern raises suspicion of profound corruption. The reasons for voting no given by some of the senators and the president read the same. The letters we got from senators look like they were either scripted by the lobbyists of the companies or cut and pasted from a talking points directive from who knows?
I wonder how these kinds of issues just fall off the feds antitrust and corruption radar!
Narayanachar S. Murali, M.D., FACP, FACGGastroenterology Associates of Orangeburg (S.C.)Digestive Endoscopy Center
Medicare Advantage plans profit by restricting care
The White House apparently does not understand what really is going on with the insurance companies that administer the Medicare Advantage programs.
These companies receive more than enough money from the government to care for our seniors. The problem lies in the fact that these insurance companies have record profits in the billions of dollars at the expense of restricted medical care for senior citizens. In addition, the government is not being fiscally responsible by allowing the drug companies to set their own pricing for the Medicare Part D program. The government should be able to have the best negotiating power with the drug companies providing services to the seniors they serve. It is completely ridiculous for the White House to want to protect the insurance companies that are bleeding the system dry instead of protecting the doctors who are providing the care.
Ana Maria Agrusa, B.S. Ed.Davie, Fla.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your letter to Modern Physician Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.